HemoShear, LLC Appoints Leading Drug Safety and Metabolism Expert, Gerald Fisher, Ph.D., to Scientific Advisory Board  
4/12/2011 8:19:58 AM

CHARLOTTESVILLE, Va.--(BUSINESS WIRE)--HemoShear LLC, a biotechnology research company and leading developer of human and animal cell-based surrogate systems for discovery and assessment of new drug compounds, announced today the appointment of Gerald Fisher, Ph.D., former Senior Vice President of Drug Safety and Metabolism at Wyeth Pharmaceuticals, to its Scientific Advisory Board.